References
- Ostro Mj. Introduction. Liposomes: from biophysics to therapeutics, Mj Ostro. Marcel Dekker, Inc., New York 1987; vii
- New RRC. Introduction. New RRC Liposomes a practical approach. Irl Press, Oxford, New York, Tokyo 1990; 1
- Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunology Today 1990; 11: 89–97
- Papahadjopoulos D. A new perspective on liposomes. Journal of Liposome Research 1992; 2: iii–xviii
- New R RC, Theakston R DG, Zumbuehl O, Iddon D, Friend J. Immunization against snake venom. New England Journal of Medicine 1984; 311: 56–57
- New R RC, Theakston R DG, Zumbuehl O, Iddon D, Friend J. Liposomal immunization against snake venom. Toxicon 1985; 23: 215–219
- Theakston R DG, Zumbuehl O, New R RC. Use of liposomes for protective immunization in sheep against Echis carinatus snake venom. Toxicon 1985; 23: 921–925
- Laing G, Theakston R DG, New R RC, Zumbuehl O, Parsley A. Use of venom incorporating immunostimulant for immunization against snake venom. Transactions of the Royal Society of Tropical Medicine and Hygiene 1986; 80: 338
- Laing G, Theakston R DG, New R RC. Use of liposomes incorporating immunostimulant for parenteral and oral immunization against snake venom. Progress in venom and toxin research, P Gopalakrishnakone, Ck Tann, Singapore 1987; 283–295
- Freitas T V, Tavares A P, Theakston R DG, Laing G, New R RC. Use of liposomes for protective immunization against Crotalus durissus terrifwus (tropical rattlesnake) venom. Toxicon 1989; 27: 341–347
- Roraanova E B, Gevashvili D B, Koshkina Nv, Torchilin Vp. Toxicity and immunogenic properties of liposomal form of Vipera libetina venom. Journal of Liposome Research 1992; 2: 205–216
- Laing G, Theakston R DG. Immunization against Echis ocellatus (Carpet viper) venom using liposomes incorporating immunostirrmlants: role of lipopolysaccharide in conferring protection in a mouse model. Toxicon 1993; 31: 615–626
- Gmner Sm. Material properties of liposomal bilayers. Liposomes: from biophysics to therapeutics, Mj Ostro. Marcel Dekker, Inc., New York 1987; 1
- Crowe L M, Crowe J H, Rodolph A, Womersley C, Appel L. Preservation of freeze-dried liposomes by trehalose. Archives of Biochemistry and Biophysics 1985; 242: 240–247
- Stewart M J, Plautz G E, Del Buono L, Yang Z Y, Xu L, Gao X, Huang L, Nabel Eg, Nabel Gj. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Human Gene Therapy 1992; 3: 267–275
- Wang C Y, Huang L. pH-sensitive immunoliposomes mediated target—cell-specific delivery and controlled expression of a foreign gene in mouse. Proceeding National Academic Science USA 1987; 84: 7851–7855
- Gregoriadis G, Florence At. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic. Drugs 1993; 45: 15–28
- FrÉZard F, Santaella C, Montisci M J, Vierling P, Riess Jg. Fluorinated phospholipid-based liposomes: H+/Na+ permeability, active doxorubicin encapsulation and stability in human serum. Biochimica Biophysica Acta 1994; 1194: 61–68
- Riess J G, FrÉZard F, Greiner J, Kraft M P, Santaella C, Vierling P, Zarif L. Membranes, vesicles and other supramolecular systems made from fluorinated amphiphiles. Handbook of non-medical applications of liposomes (III), Y Barenholz, D Lasic. CRC Press Inc. 1996; 8
- FrÉZard F, Santaella C, Vierling P, Riess Jg. Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. Biochimica et Biophysica Acta 1994; 1192: 61–70
- Vierling P, Santaella C, Riess Jg. Fluorinated liposomes. Liposomes, new systems and new trends in their applcations, F Puisieux, P Couvreur, J Delattre, Jp Devissaguet. Editions de Santé, Paris 1995; 293
- Kirby C, Gregoriadis G. Dehydration-rehydration vesicles: a simple method for high yield drug entrapment in liposomes. Biotechnology 1984; 2: 979–984
- Crowe J H, Hoekstra Fa, Crowe Lm. Anhydrobiosis. Annual Review of Physiology 1992; 54: 579–599
- Friede M, Van Regenmortel M HV, Schuber F. Liophilized liposomes and shelf items for the preparation of immunogenic liposome-peptide conjugates. Analytical Biochemistry 1993; 211: 117–122
- Crowe Lm, Crowe Jh. Freeze-dried liposomes. Liposomes, new systems and new trends in their applications, F Puisieux, P Couvreur, J Delattre, Jp Devissaguet. Editions de Santé, Paris 1995; 237
- Szoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the National Academy of Sciences of the United States of America 1978; 75: 4194–4198
- Shew Rl, Deamer Dw. A novel method for encapsulation of macromolecules in liposomes. Biochimica et Biophysica Acta 1985; 816: 1–8
- Tan L, Loyter A, Gregoriadis G. Incorporation of reconstituted influenza virus envelopes into liposomes: studies of the immune response in mice. Biochemical Society Transactions 1989; 17: 129–130
- Gregoriadis G. The carrier potential of liposomes in biology and medicine. New England Journal of Medicine 1976; 295: 704–710
- Fattal E, Ramaldes Ga, Ollivon M. Oral delivery of vaccines by means of liposomes. Liposomes, new systems and new trends in their applcations, F Puisieux, P Couvreur, J Delattre, Jp Devissaguet, 1995
- Lasic Dd, Papahadjopoulos D. Liposomes revisited. Science 1995; 267: 1275–1276
- Santaella C, Frezard F, Vierling P, Riess Jg. Extended in vivo blood circulation time of fluorinated liposomes. Federation of European Biochemical Societies Letters 1993; 336: 481–484
- Gregoriadis G, Garcon N, Senior J, Davis D. The immunoadjuvant action of liposomes: nature of immune response and influence of liposomal characteristics. Liposomes as drug carriers, G Gregoriadis. John Wiley and Sons. 1988
- Buiting A MJ, Van Rooijen N, Claassen E. Liposomes as antigen carriers and adjuvant. in vivo. Research in Immunology 1992; 143: 541–548
- Perrin P. Liposomes et vaccins. Les Liposomes -aspects technologiques, biologiques et pharmacologiques, J Delattre, P Couvreur, F Puisieux, F Philipot, Jr., Shubert, Paris 1993; 225
- Van Rooijen N, Van Nieuwmegen R. Liposomes in immunology: evidence that their adjuvant effect results from surface exposition of the antigens. Cellular immunology 1980; 49: 402–407
- Antimisiaris S G, Jayasekera P, Gregoriadis G. Liposomes as vaccine carriers: incorporation of soluble and particulate antigens in giant vesicles. Journal of Immunological Methods 1993; 166: 271–280
- Petrov A.B., Semenov B.F., Vartanyan Y.P., Zakirov M.M., Torchilin V.P., Trubetskoy V.S., Dmitriev B.A. Toxicity and immunogenicity of Neisseria meningitidis lipopolysaccharide incorporated into liposomes. Infection and Immunity 1992; 60: 3897–3903
- Barratt G, Morin C. Liposomal immunomodulators. Liposomes, new systems and new trends in their applcations, F Puisieux, P Couvreur, J Delattre, Jp Devissaguet. Editions de Sante, Paris 1995; 461
- Moran Ap. Structure-bioactiviry relationships of bacterial endotoxins. Journal of Toxicology. Toxin Reviews 1995; 14: 47–83
- Ellouz F, Adam A, Ciorbaru R, Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochemical and Biophysical Research Communications 1974; 59: 1317–1325
- Alving Cr. Lipopolysaccharide, lipid A and liposome containing lipid A as immunological adjuvants. Immunbiology 1993; 187: 430–446
- Grasset E. Anavenoms and their use in the preparation of antivenoms sera. Transactions of the Royal Society of Tropical Medicine and Hygiene 1945; 38: 463–488
- Relyveld E H, Girard O, Cheyroux M, Asso J, De Rudder J. Noveau procedè deactivation pour la preparation de vacines. Developments in Biological Standardization 1974; 27: 236–348
- Okonogi T, Hattori Z, Ogiso A, Mitsui S. Detoxification by persimmon tannin of snake venoms and bacterial toxins. Toxicon 1979; 17: 524–527
- Cardi Ba, Andrade Hf., Jr. Aumento do reconhecimento e fagocitose por macrofagos de crotoxina de C. d. terrifwus após irradiação gama. Congresso da Sociedade Brasileira de Medicina Tropical. São Paulo 1995; 31
- Daniel J P, Heneine L GD, Tavares C AP, Nascimento M CS, Neneine If. Generation of protective immune sera by Crotalus durissus terrificus venom detoxified by controlled iodination. Brazilian Journal of Medical and Biological Research 1987; 20: 713–720
- Bolanos R, Cerdas L. The production and control of anti-venoms sera. Developments in Biological Standardization 1978; 41: 109–116
- Rolim-Rosa R, Vieira E GJ, Silles-Villaroel M, Siracusa Yq, Yizuka H. Analise comparativa entre os diferentes esquemas de hiperimunização empreados na produção de soros antiofidicos do Iiistituto Butantan (1957–1979). Memorias do Institute) Butantan 1980; 44–45: 259–265
- Schaeffer Rc, Jr., Randall H, Resk J, Carlson Rw. Enzyme-linked immunosorbent assay (ELISA) of size-selected crotalid venom antigen by Wyeth's polivalent antivenom. Toxicon 1988; 26: 67–76
- Hawgood Bj. Physiological and pharmacological effects of rattlesnake venoms. Rattlesnake venoms: their applications and treatment, At Tu. Marcel Dekker, Inc., New York 1982; 121
- Kochwa S, Gitter S, Strauss A, Vriess Ad. Immunologic study of Vipera xanthina palestinae venom and preparation of potent antivenin in rabbits. Journal of Immunology 1959; 82: 107–114
- Ramlau J, Bock E, Fohlman J. Production of antivenom against detoxified taipoxin and immunochemical analysis of the ã,β and γ subunits. Toxicon 1979; 17: 43–48
- My Liau, Huang Rj, Chen Sw. Enhancement of Naja naja atra antivenin production in horses. Chinese Journal of Microbiology and Immunology 1982; 15: 294–299
- ChÁVez-OlÓRtegui C, Ait-Amara D, Rochat H, Diniz Cr, Granier C. In vivo protection against scorpion toxins by liposomal immunization. Vaccine 1991; 9: 907–911
- Fonseca S G, Ferreira A MM, Diniz Cr, ChÁVez-OlÓRtegui C. Induction of neutralizing antibodies in mice immunized with scorpion toxins detoxified by liposomal entrapment. Brazilian Journal of Medical and Biological Research 1997, (in press)
- Freitas T V, Fortes-Dias Cl, Diniz Cr. Protection against the lethal effects of Crotalus durissus terrificus (South American rattlesnake) venom in animals immunized with crotoxin. Toxicon 1990; 28: 1491–1496
- Rosenberg P. Phospholipases. Handbook of Toxinology, Wt Shier, D Mebs. Marcel Dekker, Inc., New York 1990; 67
- Freitas Tv, Frezard F. Encapsulation of native crotoxin in liposomes: a safe approach for the production of antivenom and vaccination against Crotalus durissus terrificus venom. Toxicon 1997; 35: 91–100
- De Haas Gh, Van Deenem L LM. Structural identification of isomeric lysolecithins. Biochimica et Biophysica Acta 1965; 106: 315–318
- Freitas Tv. Crotoxina, neurotoxina de veneno de Crotalus durissus terrificus, incorporada em liposomas. Federal University of Minas Gerais, Belo Horizonte, MGBrazil 1996, Ph. D thesis
- Freitas T V, Fortes-Dias C L, Diniz C R, Velarde Dt, Freitas Cf. Immunization of horses with Crotalus durissus terrificus (South American rattlesnake) venom. A comparision of four different procedures. Brazilian Journal of Medical and Biological Research 1991; 24: 281–290
- Bouwstra Ja, Junginger He. Non-ionic surfactant vesicles (niosomes) for oral and transdermal administration of drugs. Liposomes, new systems and new trends in their applcations, F Puisieux, P Couvreur, J Delattre, Jp Devissaguet. Editions de Santé, Paris 1995; 99
- Chien K Y, Chiang C M, Hseu Y C, Vyas A A, Rule Gs, Wu Wg. Two distinct types of cardiotoxin as revealed by the structure and activity relationship of their interaction with zwitterionic phospholipid dispersion. Journal of Biological Chemistry 1994; 269: 14473–14483
- BultrÓN E, Gutierrez Jm, Thelestam M. Effects of Bothrops asper (Terciopelo) myotoxin III, a basic phospholipase A2, on liposomes and mouse gastrocnemius muscle. Toxicon 1993; 31: 217–222
- Diaz C, Gutierrez Jm, Lomonte B. Isolation and characterization of basic myotoxic phospholipase A2 from Bothrops godmani (Godman's Pit Viper) snake venom. Archives of Biochemistry and Biophysics 1992; 298: 135–142
- Patel T N, Braganca Bm, Bellare Ra. Changes produced by Cobra venom cytotoxin on the morphology of yoshida sarcoma cells. Experimental Cell Research 1969; 57: 289–297
- Chaim-Matyas A, Borkow G, Ovadia M. Encapsulation of the cobra cytotoxin P4 in liposomes. Biotechnology and Applied Biochemistry 1993; 17: 31–36